Using telehealth to provide therapy for young people at risk of psychosis
Official title: Telehealth Adaptation of Group and Family-Based Cognitive Behavioral Therapy for Youth at Risk for Psychosis
Funded at Icahn School of Medicine at Mount Sinai · NIH-11007219 · Data updated 2026-11-12
This study is looking at how well online group and family therapy can help young people aged 12-20 who are at risk of developing serious mental health issues, making it easier for them to get the support they need without the usual barriers like stigma or transportation problems.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | March 7, 2023 |
| Project end | December 31, 2025 |
| Funding year | 2025 |
| Award (this year) | $177,473 |
| NIH project number | 5R34MH128502-03 |
| Project ID | NIH-11007219 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are youth aged 12-20 who are identified as being at clinical high risk for psychosis.
✕Less likely to help
Patients who are not at clinical high risk for psychosis or those outside the age range of 12-20 may not receive benefit from this research.
What this research studies
This research investigates the use of telehealth to deliver Group and Family-Based Cognitive Behavioral Therapy (GF-CBT) to youth aged 12-20 who are at clinical high risk for developing psychosis. The approach aims to reduce barriers to accessing mental health services, such as stigma and transportation issues, by providing therapy remotely. By evaluating the feasibility and acceptability of this telehealth intervention, the research seeks to improve treatment engagement and clinical outcomes for these young individuals. The program focuses on facilitating psychosocial recovery and preventing the transition to full-blown psychosis.
Why it matters
Potential benefit: If successful, this research could significantly improve access to effective mental health treatment for youth at risk of psychosis, potentially reducing the severity of their symptoms and improving their long-term functioning.
How similar studies have gone: Other research has shown promising results with telehealth interventions for mental health treatment, indicating that this approach could be effective for similar populations.
Where this research is happening
-
Icahn School of Medicine at Mount Sinai
New York, United States Active
Researchers
- Principal investigator: Landa, Yulia — Icahn School of Medicine at Mount Sinai
- Study coordinator: Landa, Yulia
Related research
Other NIH-funded projects on the same topics.
-
Psychosis in diverse settings across the world
This project studies how psychotic disorders show up and respond to treatment in adults with diverse backgrounds, including populations in Africa, the Caribbean, and other Global South settings.
-
Psychosis in Diverse Settings: Understanding Symptoms and Treatment Across Global South
A human-facing study will look at how psychotic disorders present and respond to treatment in adults from Africa, the Caribbean, and other Global South settings, using genetic and clinical data.
-
A new online brain-scan-style tool to spot early psychosis risk
A new online-based set of tasks and a computer model aims to identify people at high risk for developing psychosis earlier and more accurately.
-
Genetic clues for early-onset psychosis in Latino youth
This project looks at the genes of young people with early-onset psychosis and compares them with similar youths without psychosis to find genetic factors that contribute to the illness.
-
Biomarkers to tailor rehab for Veterans with schizophrenia
A clinician-scientist is developing a brain-based biomarker to guide personalized rehabilitation for Veterans with schizophrenia.
-
Computational analysis of facial expression in early psychosis
Aims to develop computer-based measures of facial expression in people at risk for or with schizophrenia to help track symptoms and guide future trials.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.